BIOMAT Database Logo BIOMAT Database Logo

Protein kinase C: a target for anti-inflammatory therapy? 1992

U Amon, and K R Dietz
Department of Dermatology, Medical University of Lübeck, Federal Republic of Germany.

UI MeSH Term Description Entries
D011493 Protein Kinase C An serine-threonine protein kinase that requires the presence of physiological concentrations of CALCIUM and membrane PHOSPHOLIPIDS. The additional presence of DIACYLGLYCEROLS markedly increases its sensitivity to both calcium and phospholipids. The sensitivity of the enzyme can also be increased by PHORBOL ESTERS and it is believed that protein kinase C is the receptor protein of tumor-promoting phorbol esters. Calcium Phospholipid-Dependent Protein Kinase,Calcium-Activated Phospholipid-Dependent Kinase,PKC Serine-Threonine Kinase,Phospholipid-Sensitive Calcium-Dependent Protein Kinase,Protein Kinase M,Calcium Activated Phospholipid Dependent Kinase,Calcium Phospholipid Dependent Protein Kinase,PKC Serine Threonine Kinase,Phospholipid Sensitive Calcium Dependent Protein Kinase,Phospholipid-Dependent Kinase, Calcium-Activated,Serine-Threonine Kinase, PKC
D003872 Dermatitis Any inflammation of the skin. Dermatitides
D006636 Histamine Release The secretion of histamine from mast cell and basophil granules by exocytosis. This can be initiated by a number of factors, all of which involve binding of IgE, cross-linked by antigen, to the mast cell or basophil's Fc receptors. Once released, histamine binds to a number of different target cell receptors and exerts a wide variety of effects. Histamine Liberation,Histamine Liberations,Histamine Releases
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000470 Alkaloids Organic nitrogenous bases. Many alkaloids of medical importance occur in the animal and vegetable kingdoms, and some have been synthesized. (Grant & Hackh's Chemical Dictionary, 5th ed) Alkaloid,Plant Alkaloid,Plant Alkaloids,Alkaloid, Plant,Alkaloids, Plant
D019311 Staurosporine An indolocarbazole that is a potent PROTEIN KINASE C inhibitor which enhances cAMP-mediated responses in human neuroblastoma cells. (Biochem Biophys Res Commun 1995;214(3):1114-20) 8,12-Epoxy-1H,8H-2,7b,12a-triazadibenzo(a,g)cyclonona(cde)trinden-1-one, 2,3,9,10,11,12-hexahydro-9-methoxy-8-methyl-10-(methylamino)-, (8alpha,9beta,10beta,12alpha)-(+)-

Related Publications

U Amon, and K R Dietz
Protein kinase C as a target for cancer therapy.
June 1997, Antisense & nucleic acid drug development,
U Amon, and K R Dietz
Protein kinase C: a target for therapy in pancreatic cancer.
May 2008, Pancreas,
U Amon, and K R Dietz
Protein kinase C: an attractive target for cancer therapy.
February 2011, Cancers,
U Amon, and K R Dietz
Protein kinase C--a novel target for rational anti-cancer drug design?
August 1989, Anti-cancer drug design,
U Amon, and K R Dietz
Exploitation of protein kinase C: a useful target for cancer therapy.
February 2009, Cancer treatment reviews,
U Amon, and K R Dietz
Protein kinase C in cellular transformation: a valid target for therapy?
December 2014, Biochemical Society transactions,
U Amon, and K R Dietz
Ceramide kinase: a potential anti-inflammatory target?
May 2008, Current opinion in investigational drugs (London, England : 2000),
U Amon, and K R Dietz
Protein kinase C-theta inhibitors: a novel therapy for inflammatory disorders.
January 2012, Current pharmaceutical design,
U Amon, and K R Dietz
Protein kinase C: a target for anticancer drugs?
June 2004, Endocrine-related cancer,
U Amon, and K R Dietz
Protein kinase C: a target for anticancer drugs?
September 2003, Endocrine-related cancer,
Copied contents to your clipboard!